Departments of Biostatistics and Epidemiology.
Channing Division of Network Medicine.
J Nutr. 2018 Sep 1;148(9):1445-1452. doi: 10.1093/jn/nxy129.
Early natural menopause, the cessation of ovarian function before age 45 y, is positively associated with cardiovascular disease and other conditions. Dietary vitamin D intake has been inversely associated with early menopause; however, no previous studies have evaluated risk with regard to plasma 25-hydroxyvitamin D [25(OH)D] concentrations.
We prospectively evaluated associations of total and free 25(OH)D and vitamin D-binding protein (VDBP) concentrations and the risk of early menopause in a case-control study nested within the Nurses' Health Study II (NHS2). We also considered associations of 25(OH)D and VDBP with anti-Müllerian hormone (AMH) concentrations.
The NHS2 is a prospective study in 116,430 nurses, aged 25-42 y at baseline (1989). Premenopausal plasma blood samples were collected between 1996 and 1999, from which total 25(OH)D and VDBP concentrations were measured and free 25(OH)D concentrations were calculated. Cases experienced menopause between blood collection and age 45 y (n = 328) and were matched 1:1 by age and other factors to controls who experienced menopause after age 48 y (n = 328). Conditional logistic regression models were used to estimate ORs and 95% CIs for early menopause according to each biomarker. Generalized linear models were used to estimate AMH geometric means according to each biomarker.
After adjusting for smoking and other factors, total and free 25(OH)D were not associated with early menopause. Quartile 4 compared with quartile 1 ORs were 1.04 (95% CI: 0.60, 1.81) for total 25(OH)D and 0.70 (95% CI: 0.41, 1.20) for free 25(OH)D. 25(OH)D was unrelated to AMH concentrations. VDBP was positively associated with early menopause; the OR comparing the highest with the lowest quartile of VDBP was 1.80 (95% CI: 1.09, 2.98).
Our findings suggest that total and free 25(OH)D are not importantly related to the risk of early menopause. VDBP may be associated with increased risk, but replication is warranted.
卵巢功能在 45 岁之前停止,即早期自然绝经,与心血管疾病和其他疾病呈正相关。饮食中维生素 D 的摄入量与早期绝经呈负相关;然而,以前的研究并没有评估血浆 25-羟维生素 D[25(OH)D]浓度与风险的关系。
我们在护士健康研究 II(NHS2)中进行了一项病例对照研究,前瞻性评估了总 25(OH)D 和游离 25(OH)D 以及维生素 D 结合蛋白(VDBP)浓度与早期绝经的关系。我们还考虑了 25(OH)D 和 VDBP 与抗苗勒管激素(AMH)浓度的关系。
NHS2 是一项针对 116430 名护士的前瞻性研究,基线年龄为 25-42 岁(1989 年)。1996 年至 1999 年期间采集了绝经前的血浆血样,测量了总 25(OH)D 和 VDBP 浓度,并计算了游离 25(OH)D 浓度。病例组在采血后至 45 岁时经历了绝经(n=328),并按年龄和其他因素与对照组 1:1 匹配,对照组在 48 岁后经历了绝经(n=328)。采用条件逻辑回归模型估计了根据每个生物标志物的早期绝经的比值比(OR)和 95%置信区间(CI)。采用广义线性模型根据每个生物标志物估计 AMH 的几何平均值。
调整吸烟和其他因素后,总 25(OH)D 和游离 25(OH)D 与早期绝经无关。与第 1 四分位相比,第 4 四分位的总 25(OH)D 的 OR 值为 1.04(95%CI:0.60,1.81),游离 25(OH)D 的 OR 值为 0.70(95%CI:0.41,1.20)。25(OH)D 与 AMH 浓度无关。VDBP 与早期绝经呈正相关;VDBP 最高与最低四分位数相比,OR 值为 1.80(95%CI:1.09,2.98)。
我们的研究结果表明,总 25(OH)D 和游离 25(OH)D 与早期绝经的风险没有重要关系。VDBP 可能与风险增加有关,但需要进一步证实。